Primary |
Diabetes Mellitus |
53.7% |
Type 2 Diabetes Mellitus |
17.5% |
Diabetes Mellitus Non-insulin-dependent |
8.5% |
Insulin Resistance |
3.4% |
Diabetes Mellitus Management |
2.3% |
Hypersensitivity |
1.7% |
Hypertension |
1.7% |
Polycystic Ovaries |
1.7% |
Hyperlipidaemia |
1.1% |
Metabolic Disorder |
1.1% |
Metabolic Syndrome |
1.1% |
Osteoarthritis |
1.1% |
Respiratory Tract Infection |
1.1% |
Antiplatelet Therapy |
0.6% |
Blood Cholesterol Increased |
0.6% |
Blood Pressure |
0.6% |
Drug Use For Unknown Indication |
0.6% |
Dyslipidaemia |
0.6% |
Glucose Tolerance Impaired |
0.6% |
Hepatic Steatosis |
0.6% |
|
Diarrhoea |
14.9% |
Medication Residue |
12.6% |
Blood Glucose Increased |
11.4% |
Death |
11.4% |
Weight Decreased |
6.9% |
Vomiting |
5.1% |
Blood Glucose Fluctuation |
4.0% |
Drug Ineffective |
4.0% |
Rash |
4.0% |
Myocardial Infarction |
3.4% |
Adverse Event |
2.9% |
Flatulence |
2.9% |
Nausea |
2.9% |
Muscle Spasms |
2.3% |
Pharmaceutical Product Complaint |
2.3% |
Weight Increased |
2.3% |
Alopecia |
1.7% |
Blood Glucose Abnormal |
1.7% |
Myalgia |
1.7% |
Paraesthesia |
1.7% |
|
Secondary |
Diabetes Mellitus Non-insulin-dependent |
34.4% |
Diabetes Mellitus |
16.4% |
Type 2 Diabetes Mellitus |
8.2% |
Blood Glucose Increased |
6.6% |
Alanine Aminotransferase Increased |
4.9% |
Headache |
3.3% |
Oedema |
3.3% |
Oedema Peripheral |
3.3% |
Abdominal Pain |
1.6% |
Antiplatelet Therapy |
1.6% |
Atrial Fibrillation |
1.6% |
Blood Cholesterol Increased |
1.6% |
Blood Pressure |
1.6% |
Cardiac Pacemaker Insertion |
1.6% |
Cognitive Disorder |
1.6% |
Cough |
1.6% |
Dementia |
1.6% |
Disturbance In Attention |
1.6% |
Dyslipidaemia |
1.6% |
Fluid Retention |
1.6% |
|
Myocardial Infarction |
14.7% |
Diarrhoea |
11.8% |
Weight Decreased |
11.8% |
Blood Glucose Increased |
8.8% |
Death |
8.8% |
Irritability |
5.9% |
Medication Residue |
5.9% |
Nausea |
5.9% |
Abdominal Pain |
2.9% |
Drug Ineffective |
2.9% |
Hepatitis |
2.9% |
Hypoaesthesia Facial |
2.9% |
Oedema Peripheral |
2.9% |
Renal Disorder |
2.9% |
Somnolence |
2.9% |
Thyroid Function Test Abnormal |
2.9% |
Type 2 Diabetes Mellitus |
2.9% |
|
Concomitant |
Diabetes Mellitus Non-insulin-dependent |
15.4% |
Product Used For Unknown Indication |
13.4% |
Type 2 Diabetes Mellitus |
13.3% |
Diabetes Mellitus |
12.8% |
Depression |
8.1% |
Hypertension |
7.2% |
Drug Use For Unknown Indication |
4.1% |
Blood Cholesterol Increased |
2.7% |
Anxiety |
2.3% |
Psychotic Disorder |
2.3% |
Bipolar Disorder |
2.2% |
Hyperlipidaemia |
2.2% |
Sleep Disorder |
2.1% |
Schizophrenia |
2.0% |
Gastrooesophageal Reflux Disease |
1.9% |
Hiv Infection |
1.8% |
Blood Pressure |
1.6% |
Contraception |
1.6% |
Pain |
1.6% |
Suicidal Ideation |
1.6% |
|
Weight Decreased |
25.5% |
Nausea |
7.8% |
Vomiting |
7.1% |
Renal Failure Acute |
6.7% |
Vision Blurred |
5.9% |
Blood Glucose Increased |
5.5% |
Type 2 Diabetes Mellitus |
5.5% |
Tremor |
4.3% |
Myocardial Infarction |
3.9% |
Pulmonary Embolism |
3.9% |
Weight Increased |
3.9% |
Pancreatitis |
3.1% |
Pain |
2.7% |
Breast Cancer |
2.4% |
Death |
2.4% |
Headache |
2.4% |
Sepsis |
2.0% |
Wrist Surgery |
2.0% |
Chest Pain |
1.6% |
Dyspnoea |
1.6% |
|
Interacting |
Hypertension |
30.8% |
Blood Cholesterol Increased |
15.4% |
Diabetes Mellitus |
15.4% |
Gastrooesophageal Reflux Disease |
15.4% |
Thrombosis |
15.4% |
Fluid Retention |
7.7% |
|
Dizziness Postural |
100.0% |
|